
Sign up to save your podcasts
Or


Host Lisa Skinner opens her show today with the results of her research on the most current and up-to-date information on Alzheimer's Research, and where it stands today. She shares a new drug that the pharmaceutical company, Biogen, is testing that could be a game-changer in the treatment of Alzheimer's disease or failed in the last decade as well as other very insightful information.
In her new segment, "What's News", Lisa brings you some exciting news about a new drug that the pharmaceutical company, Biogen, is testing that could be a game-changer in the treatment of Alzheimer's disease, so be sure to listen!
For more information: Up-to-date information on Alzheimer's Research
By Lisa Skinner3.9
1515 ratings
Host Lisa Skinner opens her show today with the results of her research on the most current and up-to-date information on Alzheimer's Research, and where it stands today. She shares a new drug that the pharmaceutical company, Biogen, is testing that could be a game-changer in the treatment of Alzheimer's disease or failed in the last decade as well as other very insightful information.
In her new segment, "What's News", Lisa brings you some exciting news about a new drug that the pharmaceutical company, Biogen, is testing that could be a game-changer in the treatment of Alzheimer's disease, so be sure to listen!
For more information: Up-to-date information on Alzheimer's Research

21,942 Listeners

2,034 Listeners

9,294 Listeners

1,009 Listeners

166 Listeners

9,200 Listeners

27,696 Listeners

67 Listeners

8,181 Listeners

3,327 Listeners

29,248 Listeners

9 Listeners

2,083 Listeners

20,216 Listeners

1,182 Listeners